长春高新：金赛药业GenSci141软膏注册临床试验申请获得受理

Core Viewpoint - Changchun High New Technology Industry Group Co., Ltd. (000661.SZ) announced that its subsidiary, Changchun JinSai Pharmaceutical Co., Ltd., has received the acceptance notice from the National Medical Products Administration for the clinical trial application of GenSci141 ointment [1] Group 1 - The GenSci141 ointment is a dihydrotestosterone ointment developed by JinSai Pharmaceutical, which acts on target tissues through a paracrine mechanism [1] - The product is classified as a chemical drug under categories 2.2 and 2.4 [1]